Los cannabinoides, como el cannabidiol, son muy prometedores desde el punto de vista terapéutico. Sin embargo, los formatos de administración de fármacos disponibles en la actualidad, así como la I+D en curso&D, se enfrentan a retos en lo que respecta a la absorción del API y el cumplimiento por parte del paciente. En este seminario web compartiremos los resultados de una evaluación tecnológica en profundidad para mejorar la biodisponibilidad del CBD y, al mismo tiempo, permitir formatos fáciles de usar para el paciente con una alta carga de API.
Oradores:
Explore what newly published CBtru® pharmacokinetic data means for solid oral drug development—and why clinical evidence underpins meaningful innovation.
Explore how dsm-firmenich can help pharma raise the bar in patient-centricity and sustainability.
New study confirms CBtru®, a novel CBD drug product intermediate, demonstrates equal bioavailability to leading oil-based CBD drug product.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.